This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
A common promoter hypomethylation signature in invasive breast, liver and prostate cancer cell lines reveals novel targets involved in cancer invasiveness.
Oncotarget · 2015
Latest funding
- $1,116,900
Role of methyl-CpG-binding domain protein 2 (Mbd2) in breast cancer development, progression and metastasis
CIHR · 2023 · Nominated PI
- $100,000
Targeting methyl-CpG-binding domain protein 2 (Mbd2) towards the development of next generation precision Epi-therapies against metastatic breast cancer
CIHR · 2022 · Nominated PI
- $100,000
Targeting methyl-CpG-binding domain protein 2 (Mbd2) towards the development of next generation precision Epi-therapies against metastatic breast cancer
CIHR · 2022 · Nominated PI
1 publications.
A common promoter hypomethylation signature in invasive breast, liver and prostate cancer cell lines reveals novel targets involved in cancer invasiveness.
Cheishvili D, Stefanska B, Yi C, Li CC, Yu P, Arakelian A, Tanvir I, Khan HA, Rabbani S, Szyf M
Role of methyl-CpG-binding domain protein 2 (Mbd2) in breast cancer development, progression and metastasis
Principal investigators: Rabbani, Shafaat A
Keywords: Breast Cancer; Dna Methylation; Mouse Models; Transgenic Mice; Tumour Metastasis
Targeting methyl-CpG-binding domain protein 2 (Mbd2) towards the development of next generation precision Epi-therapies against metastatic breast cancer
Principal investigators: Rabbani, Shafaat A; Szyf, Moshe
Keywords: Breast Cancer; Dna Methylation; Mouse Models; Transgenic Mice; Tumour Metastasis
Targeting methyl-CpG-binding domain protein 2 (Mbd2) towards the development of next generation precision Epi-therapies against metastatic breast cancer
Principal investigators: Rabbani, Shafaat A
Keywords: Breast Cancer; Dna Methylation; Mouse Models; Transgenic Mice; Tumour Metastasis
Urokinase plasminogen activator (uPA) and its receptor (uPAR) interaction in tumor microenvironment, therapeutic implications
Principal investigators: Rabbani, Shafaat A
Keywords: Bone Metastasis; Breast Cancer; Cancer Progression; Cancer Therapeutics; Prostate Cancer; Proteases And Growth Factors
DNA demethylation blockers; novel preventive and therapeutic approach to breast cancer development, progression and metastasis
Principal investigators: Rabbani, Shafaat A; Szyf, Moshe
Keywords: Breast Cancer; Dna Methylation; Transgenic Mice; Tumor Metastasis
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.